Vice President of AI
Turbine
Vice President of AI
Turbine
Cell-simulation platform for oncology drug discovery
Turbine · Budapest, Hungary (Hybrid) · Full-time · Posted 2026-08-18
Workplace: hybrid
Department: Engine
Join our team as a VP of AI and help virtualize biological experiments to accelerate discovery!
About Turbine
Turbine is building Virtual Assays—AI-powered predictive models that can run biological experiments in silico. We're combining deep learning with a systematic approach to biology to enable faster, cheaper, more extensive testing. Our team is small, focused, and composed of researchers and engineers who care deeply about getting biology right.
We're seeking an experienced VP of AI to lead Turbine's AI and computational biology efforts as we scale our Virtual Assay platform. In this role, you'll build and mentor a world-class team, guide technical strategy, and ensure our AI capabilities remain at the forefront of the field.
Your core mission: ensure we can scale reliable, reproducible Virtual Assay capabilities while continuously deepening our understanding of biology and improving our competitive position in the AI-driven biology space.
Key Responsibilities
You are a Turbiner if these personality traits apply to you
What We're Looking For
You bring a combination of technical depth, leadership experience, and professional visibility in the AI community:
Nice to Have
Powered by Workable
Turbine AI builds a cell simulation platform that uses machine learning to model how human cells behave and how cancer treatments may work. Their core product, Simulated Cells, runs virtual experiments to predict which drugs or targets are most likely to be effective and which patients may respond best. The platform helps pharmaceutical teams explore ideas, de-risk development, and potentially cut time and cost in bringing therapies to market. They offer a Virtual Lab to let potential clients test the technology on oncology challenges, including drug resistance in blood cancers. Turbine AI differentiates itself by combining ML-based cell simulations with targeted collaboration with pharma companies (like AstraZeneca) to apply simulations to real drug development problems and identify promising targets and patient populations that traditional lab work might miss.
Explore more opportunities at Turbine